UK markets closed
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • FTSE 250

    17,168.34
    +377.94 (+2.25%)
     
  • AIM

    806.38
    +7.99 (+1.00%)
     
  • GBP/EUR

    1.1383
    +0.0059 (+0.52%)
     
  • GBP/USD

    1.1166
    +0.0043 (+0.38%)
     
  • BTC-GBP

    17,400.78
    -163.88 (-0.93%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • S&P 500

    3,585.62
    -54.85 (-1.51%)
     
  • DOW

    28,725.51
    -500.10 (-1.71%)
     
  • CRUDE OIL

    79.74
    -1.49 (-1.83%)
     
  • GOLD FUTURES

    1,668.30
    -0.30 (-0.02%)
     
  • NIKKEI 225

    25,937.21
    -484.84 (-1.83%)
     
  • HANG SENG

    17,222.83
    +56.96 (+0.33%)
     
  • DAX

    12,114.36
    +138.81 (+1.16%)
     
  • CAC 40

    5,762.34
    +85.47 (+1.51%)
     

Global Healthcare Analytical Testing Services Market Report 2022: Growing Demand for Biosimilars Driving Sector

·3-min read
Company Logo
Company Logo

Global Healthcare Analytical Testing Services Market

Global Healthcare Analytical Testing Services Market
Global Healthcare Analytical Testing Services Market

Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report by Type (Medical Device, Pharmaceutical), by Region (APAC, North America, Europe, MEA), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global healthcare analytical testing services market size is expected to reach USD 25.1 billion by 2030, registering a CAGR of 8.3% over the forecast period, according to this report.

The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines' approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years.

Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expected to offer high growth opportunities to the providers of such services.

As pharmaceutical companies across the world have started clinical trials for the development of vaccines therapeutics, and medications for the treatment of COVID-19, the demand for analytical testing has increased. Also, to combat the coronavirus, the growing need to meet the global requirements of medical devices and pharmaceutical products, which must undergo rigorous testing before being distributed to customers, has boosted the production in the industry. This, in turn, is expected to augment the demand for such services.

Healthcare Analytical Testing Services Market Report Highlights

  • The medical device and pharmaceutical market has strict regulations so they are adopting analytical testing services that are driving the market growth

  • The Pharmaceutical Analytical Testing Services market held the largest market share of 58.5% in 2021

  • North America dominated the global market with the largest revenue share of 53.7% in 2021 owing to the presence of the largest clinical trials market in the U.S.

  • The Asia Pacific region is anticipated to grow at the fastest CAGR of 9.5% during the forecast period

  • This growth can be credited to the development and expansion of new facilities in different countries present in this region

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope

Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis

Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis

Chapter 6. Competitive Landscape

Companies Mentioned

  • Pharmaceutical Product Development

  • ICON plc

  • LabCorp

  • Charles River Laboratories International Inc.

  • Syneos Health

  • SGS SA

  • Toxikon, Inc.

  • Intertek Group

  • Pace Analytical Services, LLC

  • Eurofins Scientific

For more information about this report visit https://www.researchandmarkets.com/r/7u5iih

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900